Depressive Disorder clinical trials
The registry lists 855 studies for Depressive Disorder across more than 10 countries. 159 are recruiting or about to start. 363 of them are mainly about Depressive Disorder (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 6 narrower conditions too, such as Major Depressive Disorder: 1,955 studies, 445 open.
ClinicalTrials.gov finds 12,977 studies for Depressive Disorder. How that becomes 855 here
This page counts the studies the registry files under Depressive Disorder, and those it files under no condition that list Depressive Disorderthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count
- 12,977Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −1,096Filed under a narrower condition, counted on its own pageDepression, Postpartum 552 · Depressive Disorder, Treatment-Resistant 406 · Dysthymic Disorder 63 · Premenstrual Dysphoric Disorder 41 · Seasonal Affective Disorder 30
- −2,452List Depressive Disorder as a condition, but the registry did not file them under itMost often written as “Major Depressive Disorder” (1,538), “Depressive Disorder, Major” (286), and “Major Depressive Disorder (MDD)” (186). The registry filed 90 of them under no condition at all, and the others under other conditions only, most often Depressive Disorder, Major (2,119) and Depression (780).
- −8,574Match it another way226 name it in the title, 100 in a keyword, and 8,248 by a synonym or other text the search reads.
- 855The count on this page
Get an email when these change. Save the Depressive Disorder studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
GlaxoSmithKline (39) · National Institute of Mental Health (NIMH) (26) · VA Office of Research and Development (14) · Stanford University (13) · Sanofi (13) · New York State Psychiatric Institute (11) · Ludwig-Maximilians - University of Munich (11) · University of Oxford (10)
What is being tested here
Drugs under test in Depressive Disorder studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Fluoxetine | 2 | 2 | 8 |
| Psilocybin | 2 | 0 | 5 |
| Brenipatide | 2 | 2 | 2 |
| Ketamine | 1 | 4 | 26 |
| Vortioxetine | 1 | 7 | 10 |
| Sertraline | 1 | 0 | 8 |
| Citalopram | 1 | 1 | 7 |
| Estradiol | 1 | 0 | 2 |
| Metformin | 1 | 0 | 2 |
| Bifidobacterium spp. | 1 | 0 | 1 |
Drug classes tested here SSRIs 3 open · Serotonin receptor agonists 2 open · Psychedelics 2 open · Antipsychotics 1 open · Estrogens 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest
- Nov 2026Testing a Precision Psychotherapy System for Low-income Patients · National Council of Scientific and Technical Research, Argentina
- Nov 2026Lifestyle Intervention for Symptoms of Depression wIth App Support in General Practice · Radboud University Medical Center
- Nov 2026Feasibility of Integrated Care of Depression in Primary Care Pathways · Association De La Msp Pasteur
- Nov 2026Transcranial Direct Current Stimulation for Depression · Soterix Medical
- Dec 2026AI Mental Health Tool vs. Psychoeducation Control · Slingshot AI
- Dec 2026Assessment of Daily Stressors in Children With Depressive Symptoms for the Development of a Gamified Emotion Regulation App · Ludwig-Maximilians - University of Munich
- Dec 2026A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults · New York University
- Dec 2026Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression · Jakub Antczak
- Dec 2026Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression · Jakub Antczak
- Dec 2026Feasibility Study of UP-A-AST Parent Group for Adolescents With Autism and Co-occurring Anxiety/Depression · Sahlgrenska University Hospital
Who these studies take
Of the 115 Depressive Disorder studies recruiting now, 43 (37%) set no upper age limit and 66 (57%) stop at 75 or younger. 24 (21%) take children under 18. 7 (6%) are for women only and 0 (0%) for men only; 25 (22%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 7 (6%) | 7 (6%) |
| 18 | 95 (83%) | 90 (78%) |
| 30 | 91 (79%) | 86 (75%) |
| 40 | 89 (77%) | 84 (73%) |
| 50 | 87 (76%) | 83 (72%) |
| 65 | 82 (71%) | 79 (69%) |
| 75 | 55 (48%) | 54 (47%) |
| 85 | 47 (41%) | 46 (40%) |
Across all 855 studies, recruiting or not: 60% stop at 75 or younger and 49% at 65; 18% take children; 5% are for women only and 2% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Depressive Disorder studies take
Of 43 phase 2 interventional studies under Depressive Disorder, half reached primary completion within 30 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 5 mo1–12 · 39 studies | 3 mo1–6 · 28 studies | — |
| Phase 2 | 30 mo17–39 · 43 studies | — | — |
| Interventional, no phase | 29 mo15–46 · 274 studies | — | 29 mo15–46 · 260 studies |
| Observational | 38 mo21–104 · 57 studies | — | 39 mo19–104 · 54 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Stopped1
- Ketamine Biomarker ValidationWithdrawnOct 19, 2026NCT07307768
Newly registered3
- Concomitant Fibromyalgia and Psychiatric DisordersNov 6, 2026NCT07920913
- A Prospective Study of Anxiety, Depression, and Bipolar Disorder in PeopleOct 29, 2026NCT07903246
- Adapted Group Therapy Compared With Usual Care for Anxiety and Depression in Adults With an Autism DiagnosisOct 19, 2026NCT07880028
Studies
Recruiting first, then most recently updated. Showing 50 of 855. Browse all 855 → or search them.
- A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)RecruitingNCT07065240Phase 27 countries
- Pediatric Behavioral Health Integrated Care: Indiana Statewide Strategic Plan to Address the Growing Mental Health CrisisEnrolling by invitationNCT072166381 country
- An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)Enrolling by invitationNCT07161700Phase 27 countries
- The STEP-MIED Trial: Digital Stepped-Care for Emotional DisordersRecruitingNCT07458100Not applicable1 country
- Natural History of Depression, Bipolar Disorder and Suicide RiskRecruitingNCT064621961 country
- A Study of Brenipatide in Adult Participants With Major Depressive DisorderRecruitingNCT07412756Phase 315 countries
- A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive DisorderRecruitingNCT07775300Phase 315 countries
- A Prospective Study of Anxiety, Depression, and Bipolar Disorder in PeopleRecruitingNCT079032461 country
- Evaluation of the Effect of Light Therapy on the Evolution of Self-reported Depressive Disorders in Chronic Hemodialysis PatientsNot yet recruitingNCT07729358Not applicable1 country
- Evaluation of Depression Screening Methods Administered by Registered Nurses in Chronic Hemodialysis PatientsRecruitingNCT07651436Not applicable1 country
- Adapted Group Therapy Compared With Usual Care for Anxiety and Depression in Adults With an Autism DiagnosisNot yet recruitingNCT07880028Not applicable
- Transcranial Direct Current Stimulation for DepressionRecruitingNCT07042217Not applicable1 country
- FMRI-neurofeedback in DepressionRecruitingNCT05640089Not applicable1 country
- Deep Phenotyping for Clinical Inferring Response in Treatment Resistant DepressionRecruitingNCT063963121 country
- Evaluating a Personalised Online Program With Human Support for Women With Depression and Its Impact on Mental Health and Biological ChangesRecruitingNCT07060690Not applicable1 country
- IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 ConditionRecruitingNCT07197138Not applicable1 country
- Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant DepressionRecruitingNCT06511908Phase 21 country
- 7T Amygdala and Citalopram StudyRecruitingNCT06412315Not applicable1 country
- The Oh Happy Day Class - Digital Connections (OHDC-DC): A Pilot StudyRecruitingNCT06206226Not applicable1 country
- Unified Protocol: Community ConnectionsRecruitingNCT06038721Not applicable1 country
- Aerobic Exercise as an Adjunct Therapy for DepressionRecruitingNCT07819448Not applicable1 country
- OSU6162 as add-on in SSRI/SNRI-resistant DepressionRecruitingNCT05641623Phase 21 country
- Study on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in DepressionRecruitingNCT07813169Not applicable1 country
- Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity.RecruitingNCT06901739Not applicable1 country
- Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders, Major Depressive Disorder is Suspected to Have the Greatest Burden by 2030,Kynurenine Pathway is Major Route Through Which the Essential Amino Acid Tryptophan is Metabolised and Activated in Time of Stress and Immune Activation.Not yet recruitingNCT07771517
- A Just-in-time Adaptive Intervention for Suicide Safety Planning in AdolescentsRecruitingNCT07348666Not applicable1 country
- Feasibility, Acceptability, and Preliminary Effectiveness of Cognitive Behavioral Therapy for Depression in Autistic Youth in Clinical SettingsNot yet recruitingNCT07755137Not applicable1 country
- Creating Health Course Study for People With Rheumatological Conditions and Mood DisordersRecruitingNCT07180537Not applicable1 country
- Metformin as Adjunct Therapy in Depression-obesity Comorbidity: Clinical and Genetic EvaluationRecruitingNCT07654179Not applicable1 country
- Maternal Mindfulness: Depression and Postpartum PainRecruitingNCT05400382Not applicable1 country
- Qualitative Study of Student Financial Insecurity and PsychiatryNot yet recruitingNCT077198161 country
- Prediction on the Recurrence of Manic and Depressive Episodes in Bipolar DisorderRecruitingNCT058280561 country
- Effectiveness of Clustered Versus Tapered Repetitive Transcranial Magnetic Stimulation (rTMS) as Maintenance Therapy Following Successful Acute rTMS Treatment in Patients With Depressive SyndromeNot yet recruitingNCT07727005Not applicable1 country
- Probiotic Administration for Adolescent DepressionRecruitingNCT06898788Early Phase 11 country
- An Innovative Master Platform for Clinical Trials in Mood DisordersRecruitingNCT064080121 country
- Effectiveness of the Group Unified Protocol for Emotional Disorders in Adults in a Public Mental Health SettingRecruitingNCT07682064Not applicable1 country
- RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)RecruitingNCT07266545Phase 41 country
- Adjunctive Resonance-Based Chinese Five-Element Music Intervention for Depressive Disorders and Anxiety Symptoms in Male InpatientsEnrolling by invitationNCT07653113Not applicable1 country
- Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation on Alleviating Major Depressive Disorder in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention:A Prospective, Double-Blind,Randomized Controlled StudyRecruitingNCT07454070Not applicable1 country
- Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental IllnessRecruitingNCT05962879Not applicable1 country
- Feasibility Study of UP-A-AST Parent Group for Adolescents With Autism and Co-occurring Anxiety/DepressionRecruitingNCT07637799Not applicable1 country
- Study on Mental Health Promoting Effects of Natural Psychotherapy for AdolescentsNot yet recruitingNCT07639476Not applicable1 country
- Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput SequencingEnrolling by invitationNCT07345377Not applicable1 country
- Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional DisordersRecruitingNCT05989451Not applicable1 country
- Efficacy of a Personalized, Response-based Transdiagnostic Intervention for Emotional Disorders Delivered Via the Internet: A Protocol for an Adaptive Randomized Controlled TrialNot yet recruitingNCT07051148Not applicable
- Xiaochaihu Granules for Depression After Allogeneic Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07608029Phase 2
- Assessing the Impact of the Personalized Medicine Clinic on Mental Health OutcomesNot yet recruitingNCT07601477
- Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung CancerRecruitingNCT07216404Phase 21 country
- PB-18 Probiotic for Mild to Moderate DepressionNot yet recruitingNCT07562516Not applicable
- The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal EffectsRecruitingNCT05786066Phase 21 country